Si-Bone (SIBN) Assets Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.79% |
| Dec 31, 2025 | 3.52% |
| Sep 30, 2025 | 3.20% |
| Jun 30, 2025 | 3.16% |
| Mar 31, 2025 | 1.59% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | -1.68% |
| Jun 30, 2024 | -4.27% |
| Mar 31, 2024 | 50.07% |
| Dec 31, 2023 | 46.25% |
| Sep 30, 2023 | 45.88% |
| Jun 30, 2023 | 40.73% |
| Mar 31, 2023 | -15.70% |
| Dec 31, 2022 | -17.30% |
| Sep 30, 2022 | -18.41% |
| Jun 30, 2022 | -19.86% |
| Mar 31, 2022 | -18.03% |
| Dec 31, 2021 | -14.63% |
| Sep 30, 2021 | 25.69% |
| Jun 30, 2021 | 30.19% |
| Mar 31, 2021 | 28.57% |
| Dec 31, 2020 | 90.70% |
| Sep 30, 2020 | 27.20% |
| Jun 30, 2020 | 25.27% |
| Mar 31, 2020 | 27.08% |
| Dec 31, 2019 | -15.53% |
| Sep 30, 2019 | 327.24% |
| Dec 31, 2018 | 286.56% |